{"id":"W2263077335","doi":"10.1200/jco.2006.24.18_suppl.7543","title":"Bortezomib is active in Waldenstrom’s Macroglobulinemia (WM)—Results of a National Cancer Institute of Canada (NCIC) phase II study in previously untreated or treated WM","year":2006,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"ca_institutions":"Princess Margaret Cancer Centre; Queen Elizabeth II Health Sciences Centre; Juravinski Cancer Centre","funders":"","keywords":"Medicine; Bortezomib; Internal medicine; Waldenstrom macroglobulinemia; Macroglobulinemia; Gastroenterology; Neutropenia; Multiple myeloma; Rituximab; Nausea; Progressive disease; Marginal zone B-cell lymphoma; Surgery; Lymphoma; Chemotherapy; Immunology; B cell; Antibody; Marginal zone","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002057609,0.0009953841,0.00154011,0.0003871361,0.0004961393,0.0007409086,0.0007147698,0.0007970341,0.001277386],"category_scores_gemma":[0.0005745195,0.0004666421,0.0007775268,0.0005612423,0.0005581974,0.0003280062,0.0001990227,0.001648604,0.0004591976],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001779486,"about_ca_system_score_gemma":0.002535652,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.02171935,"about_ca_topic_score_gemma":0.07274626,"domain_scores_codex":[0.9995603,0.0001562383,0.00002472056,0.00004913787,0.00008212275,0.0001275414],"domain_scores_gemma":[0.9993228,0.00006779499,0.00007850583,0.00002879691,0.00006445457,0.0004376875],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.5210774,0.07121128,0.1121856,0.001124966,0.004701834,0.001499885,0.0007826487,0.002263097,0.1052655,0.0002232323,0.01192527,0.1677393],"study_design_scores_gemma":[0.2681659,0.3461502,0.3615675,0.0001682065,0.002150045,0.001167086,0.0002504879,0.001243827,0.007913701,0.0001424797,0.01101477,0.00006580882],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9926056,0.004508423,0.0001425471,0.0003323526,0.00004313155,0.000634735,0.000729414,0.00002491803,0.0009787764],"genre_scores_gemma":[0.9889696,0.003732922,0.0006189771,0.0009279589,0.0001351785,0.0004015038,0.003619696,0.00001755106,0.001576559],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.02171935,"threshold_uncertainty_score":0.04318583,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.112594712743701,"score_gpt":0.5001755884203875,"score_spread":0.3875808756766864,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}